MLN8237 induces proliferation arrest, expression of differentiation markers and
|
|
- Beryl Morgan
- 5 years ago
- Views:
Transcription
1 Supplementary Figure Legends Supplementary Figure induces proliferation arrest, expression of differentiation markers and polyploidization of a human erythroleukemia cell line with the activating JAK2V617F mutation. Human HEL cells were treated with DMSO, 827 () or ruxolitinib (Rux). (a) Western blot for AURKA, STAT5 and STAT in extracts of HEL cells treated with DMSO, 827 () or ruxolitinib. (b) Dose response curve for determination of the IC5s of 827 and ruxolitinib. Growth of the drug treated cells was normalized to cells treated with DMSO. (c e) Flow cytometry plots of the effect of 827 and ruxolitinib on the expression of CD41 (c), CD42 (d), and polyploidization (e) of HEL cells after 72 hrs. Data are representative of two independent experiments. Supplementary Figure induces proliferation arrest, expression of differentiation markers and polyploidization of a mouse megakaryocytic cell line overexpressing MPLW515L. Murine G1ME cells stably transduced with MPLW515L (G1ME-MPLW515L) were treated with DMSO, 827 () or ruxolitinib (Rux). (a) Dose response curve for determination of the IC5s of 827 and ruxolitinib. Growth of the drug treated cells was normalized to cells treated with DMSO. (b d) Flow cytometry plots of the effect of 827 and ruxolitinib on the expression of CD41 (b), CD42 (c), and polyploidization (d) of G1ME/MPLW515L cells after 72 hrs. Data are representative of two independent experiments. Supplementary Figure Nature Medicine: doi:1.18/nm.995 1
2 827 induces proliferation arrest, polyploidization, differentiation and apoptosis of SET-2 cells. SET-2 cells were treated with DMSO, 827 () or ruxolitinib (Rux). (a) Dose response curve for determination of the IC5s of 827 and ruxolitinib in SET-2 cells. (b e) Flow cytometry measurements of DNA content (b), expression of CD41 (c) and CD42 (d), and annexin V staining (e) 72 hrs after addition of drug. Bar graphs depict mean ± SD of two independent experiments conducted in duplicate. p.5, p.1, compared to DMSO by the unpaired two-sided Student s t test. (f,g) Western blots to assess the activation and expression of AURKA and STAT5 with increasing doses of 827 () or ruxolitinib (rux) at 6 hours (f) and 48 hours (g). Data are representative of two independent experiments. Supplementary Figure 4 Calreticulin type 1 and type 2 mutants also upregulate AURKA in murine bone marrow cells. Bone marrow Lin - cells were transduced with Migr1 vector, or vectors expressing calreticulin type 1 (CALR T1) or calreticulin type 2 (CALR T2) mutants. Cell lysates were probed with the indicated antibodies. GRB2 is shown as a loading control. Data are representative of two independent experiments. Supplementary Figure 5 Ruxolitinib and 827 differentially affect signaling in MPLW515L overexpressing cells. Bone marrow cells of mice transplanted with human MPLW515L expressing cells were treated with DMSO, 827 (), or ruxolitinib (Rux) for 24 hours. Cell lysates were probed for activation of Aurka and JAK-STAT signaling pathways. Data are representative of two independent experiments. Supplementary Figure 6 Nature Medicine: doi:1.18/nm.995 2
3 AURKA is downregulated during megakaryocyte differentiation. Murine lineage negative bone marrow cells transduced with Migr1-MPLW515L were cultured in the presence of THPO. CD41 /GFP and CD41 /GFP - cells were collected at days,, and 7. Lysates from these cells were probed with the indicated antibodies. GRB2 is shown as a loading control. Data are representative of two independent experiments. Supplementary Figure 7 Downregulation of c-myc suppresses AURKA signaling and affects megakaryocyte maturation. SET-2 cells were transduced with two different c-myc shrnas or the empty plko.1 vector. (a) Western blot showing the levels of MYC, AURKA, and STAT5 with knockdown. (b e) Cell number (b) and flow cytometry measurements of CD41 (c), CD42 (d), and Annexin V staining (e) with knockdown. Western blot data are representative of independent experiments. Bar graphs depict mean ± SD of two independent experiments conducted in duplicate. p.5, p.1, compared to plko.1 vector by the unpaired two-sided Student s t test. Supplementary Figure 8 Inhibition of AKT signaling does not affect the degree of AURKA signaling. SET-2 cells were incubated with the AKT inhibitor MK-226 for 6 hrs (a) or 48 hrs (b). Lysates were probed with the indicated antibodies by western blot. Data are representative of independent experiments. Supplementary Figure 9 AURKA is upregulated in PMF patient samples. Lysates of CD4 cells from 2 different PMF patients were probed for the indicated antibodies. GRB2 is shown as a Nature Medicine: doi:1.18/nm.995
4 loading control. Controls are cell lysates from human cord blood CD4 cells. Data are representative of 2 technical replicates. Supplementary Figure 1 AURKA is upregulated in ET and PV patient samples. Lysates of mononuclear cells from peripheral blood of ET (a) or PV (b) patients were probed for the indicated antibodies. HSC7 is shown as a loading control. Controls are cell lysates from mononuclear cells of peripheral blood from multiple healthy donors. Supplementary Figure does not affect hematopoiesis in healthy mice. Eight to ten week old healthy Balb/c mice were treated with 15mg/kg 827 bid for three weeks. (a) Body weight following treatment with 827 () versus vehicle. (b) WBC, hemoglobin, hematocrit, and platelet count in the peripheral blood following treatment with or vehicle. (c e) Flow cytometry analysis of the myeloid (Gr1 Mac1 ), erythroid (CD71 High Ter119 ), and megakaryocytic (CD41 ) lineages. (f-h) H&E stained sections of the bone marrow (f), spleen (g) and liver (h). Results are representative of 2 independent experiments. n=6 animals per group. Bar graphs and line graphs depict mean ± SD. No significant differences were found by the unpaired two-sided Student s t test. Supplementary Figure 12 Inhibition of AURKA reduces disease burden in the MPLW515L mouse model of myelofibrosis. MPLW515L mice were treated with 15mg/kg 827 () or 6mg/kg dimf (dimf) for weeks. (a) Hematocrit and hemoglobin levels in the peripheral blood with 827 (), dimf or vehicle treatment. vs vehicle, Nature Medicine: doi:1.18/nm.995 4
5 p.1; dimf vs vehicle, p.1, by two-way ANOVA. (b-e) Flow cytometry measurement of CD41 cells (b), DNA content (c) LSK cells (d) and myeloid progenitor cells (e). (f i) May-Grunwald Giemsa stained blood smears (f) and H&E stained sections of the spleen (g), lung (h), and liver (i). (j) Reticulin stained spleen sections following and dimf treatment. Results are representative of 2 independent experiments. n=6 animals per group. Bar graphs and line graphs depict mean ± SD. p.5, p.1, compared to vehicle by the unpaired two-sided Student s t test. Supplementary Figure effectively treats MPLW515L mice at later stage of disease progression. Balb/C recipients of MPLW515L bone marrow cells were treated days post-transplant with 15mg/kg 827 bid. (a) WBC and platelet counts after treatment with 827 () or vehicle. vs vehicle, p.1, by two-way ANOVA. (b,c) Spleen (b) and liver weights (c) following treatment. (d,e) Flow cytometry measurement of CD41 (d) and CD42 (d) cells in the bone marrow. (f j) May-Grunwald Giemsa stained blood smears (f) and H&E stained sections of bone marrow (g), spleen (h), lung (i), and liver (j). Results are representative of 2 independent experiments. n=6 animals per group. Bar graphs and line graphs depict mean ± SD. p.5, p.1, compared to vehicle by the unpaired two-sided Student s t test. Supplementary Figure 14 Deletion of one allele of Aurka normalizes hematopoiesis in MPLW515L disease mice. (a,b) Liver weight (a) and flow cytometry measurement of the percentage of Gr1 Mac1 cells in the bone marrow (b) of Aurka F/ or Aurka F/ MX1-Cre. (c-f) May- Grunwald Giemsa stained blood smears (c) and H&E stained sections of the spleen (d), lung (e) and liver (f). Nature Medicine: doi:1.18/nm.995 5
6 Supplementary Figure 15 Homozygous deletion of Aurka reduced the disease burden in the MPLW515L mouse model of myelofibrosis. Bone marrows from Aurka F/F or Aurka F/F MX1-Cre mice were transduced with MPLW515L and transplanted into recipient mice. Three weeks later, pi-pc was injected into recipients to induce excision of Aurka by MX1-Cre. (a) Deletion of the floxed region, excision products and MX1-Cre expression were monitored by PCR in the peripheral blood (PB), spleen (Sp) and bone marrow (BM) of recipient mice 19 days after the first injection of pi-pc. (b f) White cell count (b), hematocrit (c), hemoglobin (d) platelet count (e) and percentage of GFP cells (f) in the peripheral blood. (g-i) Spleen (g), liver (h) and body weights (i) of the two groups of mice. Results are representative of 2 independent experiments. n=5 animals per group. Bar graphs depict mean ± SD. p.5, p.1, compared to Aurka F/F mice by the unpaired twosided Student s t test. Nature Medicine: doi:1.18/nm.995 6
7 Cell no. CD42 CD41 Supplementary figure 1 a (μm) DMSO Rux (μm) DMSO. 1 1 b p-aurka AURKA p-stat5 STAT5 (μm) DMSO. 1 1 Rux (μm) DMSO. 1 1 Relative cell growth Rux IC5 = 4 nm IC5 = 26.5 nm p-stat STAT Log [Conc] (M) c DMSO.1 µm 1 µm Rux.1µM Rux 1 µm SSC d e SSC DAPI Nature Medicine: doi:1.18/nm.995
8 Cell no. CD42 CD41 Supplementary figure 2 a Relative cell growth.6. Rux IC5 = 961 nm IC5 = 9 nm b Log [Conc] (M) DMSO.1 µm 1 µm Rux.1 µm Rux 1 µm SSC c SSC d DAPI Nature Medicine: doi:1.18/nm.995
9 Supplementary figure a6 Cell no. ( 1 ) Rux IC5 = 22.6 nm IC5 = 5.5 nm b 4 8N (%) c Log Conc (M) 12 d.1 µm 1 µm Rux.1 µm Rux 1 µm CD41 (%) CD42 (%) e 15.1 µm 1 µm 15 Rux.1 µm Rux 1 µm.1 µm 1 µm Rux.1 µm Rux 1 µm Annexin V (%) µm 1 µm Rux.1 µm Rux 1 µm f (μm) Rux (μm) g (μm) Rux (μm) DMSO.1. 1 DMSO.1. 1 DMSO.1. 1 DMSO.1. p-aurka AURKA p-stat5 STAT5 c-myc GRB2 Nature Medicine: doi:1.18/nm.995
10 Supplementary figure 4 AURKA p-stat5 STAT5 GRB2 Migr1 CalR CalR vector T1 T2 Nature Medicine: doi:1.18/nm.995
11 Supplementary figure 5 (μm) DMSO p-aurka Rux (μm) DMSO AURKA p-stat5 STAT5 p-stat STAT GRB2 Nature Medicine: doi:1.18/nm.995
12 Supplementary figure 6 p-aurka AURKA p-stat5 MPLW515L MK D D D7 MPLW515L- MK D D STAT5 GRB2 Nature Medicine: doi:1.18/nm.995
13 Supplementary figure 7 a b c 12.9 plko.1 Sh4 Sh42 p-aurka AURKA p-stat5 STAT5 c-myc GRB2 6 Cell no. ( 1 ).6.. CD41 (%) PLKO Sh4 Sh42 PLKO Sh4 Sh d e CD42 (%) 5 Annexin V (%) PLKO Sh4 Sh42 PLKO Sh4 Sh42 1 Nature Medicine: doi:1.18/nm.995
14 Supplementary figure 8 a p-aurka MK-226 (μm) DMSO. 1 1 b MK-226 (μm) DMSO. 1 1 AURKA p-akt AKT HSC7 Nature Medicine: doi:1.18/nm.995
15 Supplementary figure 9 p-aurka Ctrl PMF Ctrl PMF4 AURKA GRB2 Nature Medicine: doi:1.18/nm.995
16 Supplementary figure 1 a Ctrl ET1 ET2 Ctrl ET ET4 p-aurka AURKA HSC7 b Ctrl PV1 PV2 Ctrl PV PV4 p-stat5 Ctrl ET1 ET2 Ctrl ET ET4 Ctrl PV1 PV2 Ctrl PV PV4 STAT5 HSC7 Ctrl ET1 ET2 Ctrl ET Ctrl PV1 PV2 Ctrl PV PV4 c-myc HSC7 Nature Medicine: doi:1.18/nm.995
17 High Supplementary figure 11 a Body weight (g) b 1 8 WBC ( 1 /µl) Hematocrit (%) Platelets ( 1 /µl) 1, c Time after treatment (weeks) d 4 e 2.5 Gr1 /Mac1 (%) CD71 /Ter119 (%) 2 1 CD41 (%) f. g h Nature Medicine: doi:1.18/nm.995
18 Supplementary figure 12 a Hematocrit (%) Hemoglobin (g/dl) b dimf CD41 (%) c Time after treatment (weeks) d Time after treatment (weeks) e 5 dimf vs, p=.7 8N (%) 2 1 LSK (%) Myeloid progenitors (%) f. dimf dimf dimf dimf g h i j Nature Medicine: doi:1.18/nm.995
19 Supplementary figure 1 a WBC ( 1 /µl) 2 1 Platelets ( 1 /µl) 4,, 2, 1, b 1.5 Spleen weight (g) 1..5 c Time after treatment (days) d Time after treatment (days) e Liver weight (g) 2 1 CD41 (%) 4 2 CD42 (%) 2 1 f g h i j Nature Medicine: doi:1.18/nm.995
20 Supplementary figure 14 a Liver weight (g) 2 1 b Gr1 /Mac1 (%) c Aurka F/ MX1-Cre Aurka F/ Aurka F/ MX1-Cre Aurka F/ d Aurka F/ Aurka F/ MX1-Cre Aurka F/ Aurka F/ MX1-Cre e f Nature Medicine: doi:1.18/nm.995
21 Supplementary figure 15 a F/F F/F Aurka MX1-Cre Aurka F/F Aurka MX1-Cre Aurka F/F F/F Aurka MX1-Cre Aurka F/F Flox WT Excision MX1-Cre PB Sp BM b c d WBC ( 1 /µl) 1 5 Aurka F/F MX1-Cre Aurka F/F Hematocrit (%) e f g 2, 1 Aurka F/F MX1-Cre Aurka F/F Hemoglobin (g/dl) Aurka F/F MX1-Cre Aurka F/F Platelets ( 1 /µl) 1,5 1, 5 GFP (%) Spleen weight (g) h 4 Aurka F/F MX1-Cre Aurka F/F ibody Weight (g) 25 Aurka F/F MX1-Cre Aurka F/F. Aurka F/F MX1-Cre Aurka F/F Liver weight (g) Aurka F/F MX1-Cre Aurka F/F Aurka F/F MX1-Cre Aurka F/F Nature Medicine: doi:1.18/nm.995
22 Table S1 PMF patient information Patient # Gender Age Ethnicity Mutations DIPSS- plus Risk score category 1 Female 7 Caucasian MPL W515 2 int- 2 2 Female 6 African American JAK2V617F 2 int- 2 Male 6 Native Hawaiian/ Pacific Islander CALR (22bp del) 2 int- 1 4 Male 71 Caucasian JAK2V617F 6 high risk 5 Female 62 Caucasian CALR(5bp ins) 6 high risk 6 Female 42 African American CALR (52bp del) 6 high risk 7 Male 7 Caucasian JAK2V617F int- 2 8 Female 51 Caucasian JAK2V617F low risk 9 Female 66 Caucasian JAK2V617F 1 int- 1 1 Male 69 Caucasian CALR (E79fs47; del) int Male 69 Caucasian JAK2V617F 1 int Male 61 Caucasian Triple negative int- 2 1 Male 6 Caucasian JAK2V617F int Male 65 Caucasian CALR (K75fs52; del) int- 2 Nature Medicine: doi:1.18/nm.995
23 Table S2 ET and PV patient information Patient # Gender Age Ethnicity Mutations ET1 Female 42 Caucasian JAK2V617F ET2 Female 59 Caucasian JAK2V617F ET Female 41 Caucasian CALR (52bp del) ET4 Male 64 Caucasian JAK2V617F PV1 Male 6 Caucasian JAK2V617F PV2 Female 19 Caucasian JAK2V617F PV Female 68 Caucasian JAK2V617F PV4 Female 52 Caucasian JAK2V617F Nature Medicine: doi:1.18/nm.995
24 Table S Synergy between 827 and Ruxolitinib Multiples of IC5 Conc (μm) Rux Conc (μm) Combination incex E- 15 Nature Medicine: doi:1.18/nm.995
Murine TGFβ-antagonist (RAP-1332) Inhibits Fibrosis in a Murine Model of Myelofibrosis. Rajasekhar NVS Suragani, PhD
Murine TGFβ-antagonist (RAP-1332) Inhibits Fibrosis in a Murine Model of Myelofibrosis Rajasekhar NVS Suragani, PhD Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF)
More informationSupplementary Figure 1. Xbp1 deficiency does not alter hematopoietic cellularity.
Supplementary Figure 1 Xbp1 deficiency does not alter hematopoietic cellularity. Absolute number of leukocytes obtained from bone marrow (BM, 2 tibias and 2 femurs per mouse) of Xbp1 f/f and Xbp1 Vav1
More informationSupplementary Fig. 1: Characterization of Asxl2 -/- mouse model. (a) HSCs and their
Supplementary Fig. 1: Characterization of Asxl2 -/- mouse model. (a) HSCs and their differentiated cell populations were sorted from the BM of WT mice using respective surface markers, and Asxl2 mrna expression
More informationSUPPLEMENTARY INFORMATION
DOI: 1.138/ncb3342 EV O/E 13 4 B Relative expression 1..8.6.4.2 shctl Pcdh2_1 C Pcdh2_2 Number of shrns 12 8 4 293T mterc +/+ G3 mterc -/- D % of GFP + cells 1 8 6 4 2 Per2 p=.2 p>
More information88.7 <GFP-A>: EGFP GFP. Null. % of Cells! <APC-A> B220!
B. C. 1 Cell Number (X18) A. % of Cells % of Max 8 Con 6 4 88.7 1 13 14 : EGFP 4 6 4 1 WT 8 % of% ofcells Max 6 6 4 G. 1 13 B Hdac3-/- 14 15 1 13 14 15 Ter119 Ly6C Wild type WT 4
More informationSupplementary Figure 1 Caspase-8 deficient platelets respond normally to agonists and ABT-737 (A) Surface expression of GPIX, GPIb, GPVI and CD41
Supplementary Figure 1 Caspase-8 deficient platelets respond normally to agonists and ABT-737 (A) Surface expression of GPIX, GPIb, GPVI and CD41 were assessed on purified platelets from Casp8 fl/fl and
More informationa KYSE270-CON KYSE270-Id1
a KYSE27-CON KYSE27- shcon shcon sh b Human Mouse CD31 Relative MVD 3.5 3 2.5 2 1.5 1.5 *** *** c KYSE15 KYSE27 sirna (nm) 5 1 Id2 Id2 sirna 5 1 sirna (nm) 5 1 Id2 sirna 5 1 Id2 [h] (pg per ml) d 3 2 1
More informationRevised: RG-RV2 by Fukuhara et al.
Supplemental Figure 1 The generation of Spns2 conditional knockout mice. (A) Schematic representation of the wild type Spns2 locus (Spns2 + ), the targeted allele, the floxed allele (Spns2 f ) and the
More informationSupplemental Information Inventory
Cell Stem Cell, Volume 6 Supplemental Information Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1 Grant A. Challen, Nathan C. Boles, Stuart M. Chambers, and Margaret A.
More informationFigure S1. Specificity of polyclonal anti stabilin-1 and anti stabilin-2 antibodies Lysates of 293T cells transfected with empty vector, mouse
Figure S1. Specificity of polyclonal anti stabilin-1 and anti stabilin-2 antibodies Lysates of 293T cells transfected with empty vector, mouse stabilin-1, or mouse stabilin-2 were immunoblotted using anti
More informationSUPPLEMENTARY FIG. S2. Expression of single HLA loci in shns- and shb 2 m-transduced MKs. Expression of HLA class I antigens (HLA-ABC) as well as
Supplementary Data Supplementary Methods Flow cytometric analysis of HLA class I single locus expression Expression of single HLA loci (HLA-A and HLA-B) by shns- and shb 2 m-transduced megakaryocytes (MKs)
More informationSupplementary Figure 1. IFN-γ induces TRC dormancy. a, IFN-γ induced dormancy
Supplementary Figure 1. IFN-γ induces TRC dormancy. a, IFN-γ induced dormancy of various tumor type TRCs, including H22 (murine hepatocarcinoma) and CT26 (murine colon cancer). Bar, 50 µm. b, B16 cells
More informationshow PB hemoglobin concentration (Hgb) and platelet counts (Plt) in Kras ex3op/ex3op mice
Supplemental Data Supplemental Figure Legends Supplemental Figure 1. Hematologic profile of Kras / mice. (A) Scatter plots show PB hemoglobin concentration (Hgb) and platelet counts (Plt) in Kras / mice
More informationSupplementary Figure 1 Pfn1, but not other Pfn isoforms are expressed in
Supplementary Figure 1 Pfn1, but not other Pfn isoforms are expressed in platelets. (a) RT-PCR of Pfn isoforms in control mouse platelets, Pfn1 -/- platelets and control heart. Expected band size for Pfn1
More information(A-B) P2ry14 expression was assessed by (A) genotyping (upper arrow: WT; lower
Supplementary Figures S1. (A-B) P2ry14 expression was assessed by (A) genotyping (upper arrow: ; lower arrow: KO) and (B) q-pcr analysis with Lin- cells, The white vertical line in panel A indicates that
More informationSupplemental Table S1. RT-PCR primers used in this study
Supplemental Table S1. RT-PCR primers used in this study -----------------------------------------------------------------------------------------------------------------------------------------------
More informationSupplementary Figure 1. Bone density was decreased in osteoclast-lineage cell specific Gna13 deficient mice. (a-c) PCR genotyping of mice by mouse
Supplementary Figure 1. Bone density was decreased in osteoclast-lineage cell specific Gna13 deficient mice. (a-c) PCR genotyping of mice by mouse tail DNA. Primers were designed to detect Gna13-WT/f (~400bp/470bp)
More informationFlow cytometry Stained cells were analyzed and sorted by SORP FACS Aria (BD Biosciences).
Mice C57BL/6-Ly5.1 or -Ly5.2 congenic mice were used for LSK transduction and competitive repopulation assays. Animal care was in accordance with the guidelines of Keio University for animal and recombinant
More informationSupplemental figure 1: Phenotype of IMC and MDSC after purification. A. Gating
Supplemental Figure Legend: Supplemental figure 1: Phenotype of IMC and MDSC after purification. A. Gating strategy for mouse MDSC. CD11b + Ly6C high Ly6G - cells are defined as M-MDSC. CD11b + Ly6C low
More informationNature Biotechnology: doi: /nbt Supplementary Figure 1
Supplementary Figure 1 Schematic and results of screening the combinatorial antibody library for Sox2 replacement activity. A single batch of MEFs were plated and transduced with doxycycline inducible
More informationMicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen et al., page 1 MicroRNAs Modulate Hematopoietic Lineage Differentiation Chang-Zheng Chen, Ling Li, Harvey F. Lodish, David. Bartel Supplemental Online Material Methods Cell isolation Murine bone marrow
More informationa Lamtor1 (gene) b Lamtor1 (mrna) c WT Lamtor1 Lamtor1 flox Lamtor2 A.U. p = LysM-Cre Lamtor3 Lamtor4 Lamtor5 BMDMs: Φ WT Φ KO β-actin WT BMDMs
a Lamtor (gene) b Lamtor (mrna) c BMDMs: Φ WT Φ KO Lamtor flox 8 bp LysM-Cre 93 bp..5 p =.4 WT BMDMs: Φ WT Φ KO Lamtor (protein) BMDMs: Φ WT Φ KO Lamtor 8 kda Lamtor 4 kda Lamtor3 4 kda Lamtor4 kda Lamtor5.5
More informationLNK primers PCR and sequencing primers for LNK exons 2 through 7, covering the PH and SH2 domains, were designed as follows:
Clinical samples Peripheral blood (PB) samples were obtained in sodium heparin and stimulated immediately with cytokines, or following isolation of peripheral blood mononuclear cells (PBMCs) with Ficoll
More informationSUPPLEMENTAL METHODS. Chromatin immunoprecipitation (ChIP) assay. Cell culture. Non-ablated mouse transplantation. Hematology and flow cytometry
SUPPLEMENTAL METHODS Cell culture EML C1 cells were cultured in IMDM 20% horse serum, 1% antibiotic-antimycotic (Gibco by Life Technologies) 15% SCF conditioned medium from BHK/ MKL cells or 50 100 ng/ml
More informationSupplementary Figure 1: Analysis of monocyte subsets and lineage relationships. (a) Gating strategy for definition of MDP and cmop populations in BM
Supplementary Figure 1: Analysis of monocyte subsets and lineage relationships. (a) Gating strategy for definition of MDP and cmop populations in BM of Cx3cr1 GFP/+ mice related to Fig. 1a. MDP was defined
More informationRorα is essential for nuocyte development
Rorα is essential for nuocyte development See Heng Wong,,, Jennifer A. Walker,, Helen E. Jolin,, Lesley F. Drynan, Emily Hams 3, Ana Camelo, Jillian L. Barlow, Daniel R. Neill,6, Veera Panova, Ute Koch,
More informationSupplementary Materials for
www.sciencetranslationalmedicine.org/cgi/content/full//458/eaas956/dc Supplementary Materials for Thrombopoietin receptor independent stimulation of hematopoietic stem cells by eltrombopag Yun-Ruei Kao,
More informationSupplementary Figure 1. Homozygous rag2 E450fs mutants are healthy and viable similar to wild-type and heterozygous siblings.
Supplementary Figure 1 Homozygous rag2 E450fs mutants are healthy and viable similar to wild-type and heterozygous siblings. (left) Representative bright-field images of wild type (wt), heterozygous (het)
More informationSupplemental Figure 1
Supplemental Figure 1 A P1 NOD - SCID(X*X*)(0/0) NOD - SCID(X*Y)(A*0201/A*0201) B F1 (X*X)(A*0201/0) (X*X*)(0/0) F2 (X*X*)(0/0) (X*Y)(0/0) (X*X*)(A*0201/0) (X*X*)(A*0201/0) F3 (X*X*)(0/0) (X*X)(A*0201/0)
More informationSupplementary Figure Legend
Supplementary Figure Legend Supplementary Figure S1. Effects of MMP-1 silencing on HEp3-hi/diss cell proliferation in 2D and 3D culture conditions. (A) Downregulation of MMP-1 expression in HEp3-hi/diss
More informationSupplementary Fig. 1 Proteomic analysis of ATR-interacting proteins. ATR, ARID1A and
Supplementary Figure Legend: Supplementary Fig. 1 Proteomic analysis of ATR-interacting proteins. ATR, ARID1A and ATRIP protein peptides identified from our mass spectrum analysis were shown. Supplementary
More informationSupplementary Figures
Supplementary Figures Supplementary Figure 1: Phenotypically defined hematopoietic stem and progenitor cell populations show distinct mitochondrial activity and mass. (A) Isolation by FACS of commonly
More informationSupplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence
1 5 6 7 8 9 10 11 1 1 1 Supplementary Figure 1. Characterization of the POP transcriptional and post-transcriptional regulatory elements. (A) POP nucleotide sequence depicting the consensus sequence for
More informationMolecular Oncology Research Institute Hematology/Oncology Division Tufts Medical Center Boston, MA USA. 5th Annual International Symposium on MDS/MPN
What have JAK2 V617 617F transgenic mouse models taught us? Rick Van Etten, M.D., Ph.D. Molecular Oncology Research Institute Hematology/Oncology Division Tufts Medical Center Boston, MA USA 5th Annual
More informationMouse expression data were normalized using the robust multiarray algorithm (1) using
Supplementary Information Bioinformatics statistical analysis of microarray data Mouse expression data were normalized using the robust multiarray algorithm (1) using a custom probe set definition that
More informationSupplementary Figure 1
Supplementary Figure 1 Supplementary Fig. 1 shrna mediated knockdown of ZRSR2 in K562 and 293T cells. (a) ZRSR2 transcript levels in stably transduced K562 cells were determined using qrt-pcr. GAPDH was
More informationCell proliferation was measured with Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan).
1 2 3 4 5 6 7 8 Supplemental Materials and Methods Cell proliferation assay Cell proliferation was measured with Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto, Japan). GCs were plated at 96-well
More informationSupplementary Information
1 2 Supplementary Information 3 4 5 6 7 8 Supplementary Figure 1. Loading of R837 into PLGA nanoparticles. The loading efficiency (a) and loading capacity (b) of R837 by PLGA nanoparticles obtained at
More information0.9 5 H M L E R -C tr l in T w is t1 C M
a. b. c. d. e. f. g. h. 2.5 C elltiter-g lo A ssay 1.1 5 M T S a s s a y Lum inescence (A.U.) 2.0 1.5 1.0 0.5 n s H M L E R -C tr l in C tr l C M H M L E R -C tr l in S n a il1 C M A bsorbance (@ 490nm
More informationSupplementary Information Supplementary Figure 1
Bararia, Kwok et al, Supplementary Page 1 Supplementary Information Supplementary Figure 1 S1 Bararia, Kwok et al, Supplementary Page 2 Supplementary Figure 1 (cont.) S2 Bararia, Kwok et al, Supplementary
More informationSupplementary. amount of cells
Figure 1: Foxm1 expression in early B cell development-sorting strategy and verification (A) BM from a healthy donor was stained and sorted as described in (van Zelm et al., 2005), reanalysis after the
More informationFigure S1. Phenotypic characterization of transfected ECFC. (a) ECFC were transfected using a lentivirus with a vector encoding for either human EPO
Figure S1. Phenotypic characterization of transfected ECFC. (a) ECFC were transfected using a lentivirus with a vector encoding for either human EPO (epoecfc) or LacZ (laczecfc) under control of a cytomegalovirus
More information7-amino actinomycin D (7ADD) was added to all samples 10 minutes prior to analysis on the flow cytometer in order to gate 7AAD viable cells.
Antibody staining for Ho uptake analyses For HSC staining, 10 7 BM cells from Ho perfused mice were stained with biotinylated lineage antibodies (CD3, CD5, B220, CD11b, Gr-1, CD41, Ter119), anti Sca-1-PECY7,
More informationNature Biotechnology: doi: /nbt Supplementary Figure 1
Supplementary Figure 1 Generation of the AARE-Gene system construct. (a) Position and sequence alignment of AAREs extracted from human Trb3, Chop or Atf3 promoters. AARE core sequences are boxed in grey.
More informationb alternative classical none
Supplementary Figure. 1: Related to Figure.1 a d e b alternative classical none NIK P-IkBa Total IkBa Tubulin P52 (Lighter) P52 (Darker) RelB (Lighter) RelB (Darker) HDAC1 Control-Sh RelB-Sh NF-kB2-Sh
More informationDRG Pituitary Cerebral Cortex
Liver Spinal cord Pons Atg5 -/- Atg5 +/+ DRG Pituitary Cerebral Cortex WT KO Supplementary Figure S1 Ubiquitin-positive IBs accumulate in Atg5 -/- tissues. Atg5 -/- neonatal tissues were fixed and decalcified.
More informationSupplemental Fig. 1: PEA-15 knockdown efficiency assessed by immunohistochemistry and qpcr
Supplemental figure legends Supplemental Fig. 1: PEA-15 knockdown efficiency assessed by immunohistochemistry and qpcr A, LβT2 cells were transfected with either scrambled or PEA-15 sirna. Cells were then
More informationSupplementary Fig. 1. Multiple five micron sections of liver tissues of rats treated
Supplementary Figure Legends Supplementary Fig. 1. Multiple five micron sections of liver tissues of rats treated with either vehicle (left; n=3) or CCl 4 (right; n=3) were co-immunostained for NRP-1 (green)
More informationSupplementary Information
Supplementary Information Supplementary Figures Supplementary Figure 1. MLK1-4 phosphorylate MEK in the presence of RAF inhibitors. (a) H157 cells were transiently transfected with Flag- or HA-tagged MLK1-4
More informationSupplementary information
Supplementary information Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer Je-In Youn, Vinit Kumar, Michelle Collazo, Yulia Nefedova, Thomas Condamine,
More informationASH MEETING MPN REPORT December 2014 By John Crispino
ASH MEETING MPN REPORT December 2014 By John Crispino Attending the ASH meeting this year was an exercise in multitasking and endurance. MPN research and reporting continued to stand out as one of the
More informationSupplementary Figures and Legends.
Supplementary Figures and Legends. Supplementary Figure 1: Impact of injury on Rb1 and PPARϒ expression. Following ipsilateral axotomy injury, adult DRG expression of Rb1 mrna declined (*p
More informationSupplementary Figure 1. Reconstitution of human-acquired lymphoid system in
Supplementary Figure 1. Reconstitution of human-acquired lymphoid system in mouse NOD/SCID/Jak3 null mice were transplanted with human CD34 + hematopoietic stem cells. (Top) Four weeks after the transplantation
More informationSupplementary Fig. 1 (Li et al.)
Supplementary Fig. 1 (Li et al.) Fcrg / Supplementary Figure 1 Microcomputed tomography (mct) images of the distal femurs isolated from the indicated bone marrow chimeric mice. indicates the Dap12 -/-
More informationadministration of tamoxifen. Bars show mean ± s.e.m (n=10-11). P-value was determined by
Supplementary Figure 1. Chimerism of CD45.2 + GFP + cells at 1 month post transplantation No significant changes were detected in chimerism of CD45.2 + GFP + cells between recipient mice repopulated with
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature09732 Supplementary Figure 1: Depletion of Fbw7 results in elevated Mcl-1 abundance. a, Total thymocytes from 8-wk-old Lck-Cre/Fbw7 +/fl (Control) or Lck-Cre/Fbw7 fl/fl (Fbw7 KO) mice
More informationSupplementary Figure 1. Generation of B2M -/- ESCs. Nature Biotechnology: doi: /nbt.3860
Supplementary Figure 1 Generation of B2M -/- ESCs. (a) Maps of the B2M alleles in cells with the indicated B2M genotypes. Probes and restriction enzymes used in Southern blots are indicated (H, Hind III;
More informationisolated from ctr and pictreated mice. Activation of effector CD4 +
Supplementary Figure 1 Bystander inflammation conditioned T reg cells have normal functional suppressive activity and ex vivo phenotype. WT Balb/c mice were treated with polyi:c (pic) or PBS (ctr) via
More informationDOI: 10.1038/ncb3259 A Ismail et al. Supplementary Figure 1 B 60000 45000 SSC 30000 15000 Live cells 0 0 15000 30000 45000 60000 FSC- PARR 60000 45000 PARR Width 30000 FSC- 15000 Single cells 0 0 15000
More informationSupplemental Figure 1
Supplemental Figure 1 A IL-12p7 (pg/ml) 7 6 4 3 2 1 Medium then TLR ligands MDP then TLR ligands Medium then TLR ligands + MDP MDP then TLR ligands + MDP B IL-12p4 (ng/ml) 1.2 1..8.6.4.2. Medium MDP Medium
More informationAbout ATCC. Established partner to global researchers and scientists
Discovering ATCC Primary Immunology Cells - Model Systems to Study the Immune and Cardiovascular Systems James Clinton, Ph.D. Scientist, ATCC July 14, 2016 About ATCC Founded in 1925, ATCC is a non-profit
More information(a) Scheme depicting the strategy used to generate the ko and conditional alleles. (b) RT-PCR for
Supplementary Figure 1 Generation of Diaph3 ko mice. (a) Scheme depicting the strategy used to generate the ko and conditional alleles. (b) RT-PCR for different regions of Diaph3 mrna from WT, heterozygote
More informationNature Immunology: doi: /ni.3694
Supplementary Figure 1 Expression of Bhlhe41 and Bhlhe40 in B cell development and mature B cell subsets. (a) Scatter plot showing differential expression of genes between splenic B-1a cells and follicular
More informationAlleviation of skin inflammation after Lin - cell transplantation correlates with their differentiation into myeloid-derived suppressor cells
Alleviation of skin inflammation after Lin - cell transplantation correlates with their differentiation into myeloid-derived suppressor cells Su Jeong Ryu 1, Ji-Min Ju 1, Woojin Kim 1, Min Bom Kim 1, Kuen
More informationSupplementary Figure 1, related to Figure 1. GAS5 is highly expressed in the cytoplasm of hescs, and positively correlates with pluripotency.
Supplementary Figure 1, related to Figure 1. GAS5 is highly expressed in the cytoplasm of hescs, and positively correlates with pluripotency. (a) Transfection of different concentration of GAS5-overexpressing
More informationthe tamoxifen treatment schedule used to induce recombination. Arrows indicate on which
SUPPLEMENTAL DATA Figure S1. Characterization of Vhl / mice. (A) Left panel shows a schematic outline of the tamoxifen treatment schedule used to induce recombination. Arrows indicate on which days tamoxifen
More informationDual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation *Silvia Laura Locatelli, 1 Giuseppa Careddu, 1 Giuliano Giuseppe Stirparo, 1 Luca Castagna,
More informationSupplemental Figure 1: CIP2A and SET levels are increased in some. primary human pancreatic cancer samples. (A) CIP2A mrna levels were
Supplemental Figure Legends and Figures: Supplemental Figure 1: CIP2A and SET levels are increased in some primary human pancreatic cancer samples. (A) CIP2A mrna levels were measured in 3 benign (non-cancer)
More informationSupporting Information
(xe number cells) LSK (% gated) Supporting Information Youm et al../pnas. SI Materials and Methods Quantification of sjtrecs. CD + T subsets were isolated from splenocytes using mouse CD + T cells positive
More informationAccelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells. in the injured sites
Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites Yunyuan Li, Reza Baradar Jalili, Aziz Ghahary Department of Surgery, University of British Columbia,
More informationSupplementary Figure 1. In vitro activity screen of PLK1 sirna sequences. Activity of native PLK1 sirna sequences targeting human PLK1 mrna were
Supplementary Figure legends Supplementary Figure 1. In vitro activity screen of PLK1 sirna sequences. Activity of native PLK1 sirna sequences targeting human PLK1 mrna were assessed in the HT29 cell viability
More informationThe GOODELL laboratory
The GOODELL laboratory Author Nathan Boles Feb.5, 2009 Title Hematopoietic Progenitor Staining Introduction This protocol describes the analysis or isolation of the early hematopoietic progenitors. HBSS+
More informationNature Immunology: doi: /ni Supplementary Figure 1
Supplementary Figure 1 Validation of the monoclonal antibody to mouse ACKR1 and expression of ACKR1 by BM hematopoietic cells. (a to d) Comparison of immunostaining of BM cells by anti-mouse ACKR1 antibodies:
More informationSupplementary Materials for
advances.sciencemag.org/cgi/content/full/4/9/eaat5401/dc1 Supplementary Materials for GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune
More information* * IgL locus (V - J ) λ λ
Supplementary Figures and Figure Legend Supplementary Figure S1 A C F Vav-P-BCL2 doner mice 8 6 4 2 Lymphoma free (%)1 Tumor Pathology Score Retroviral transduction Vav-P-BCL2 HPCs HPC + shrna VavP-Bcl2
More informationSupplementary Information. Conversion of vascular endothelial cells into multipotent stem-like cells
Supplementary Information Conversion of vascular endothelial cells into multipotent stem-like cells Damian Medici 1, Eileen M. Shore 2,3,4, Vitali Y. Lounev 2,4, Frederick S. Kaplan 2,4,5, Raghu Kalluri
More informationSupplemental Information. The TRAIL-Induced Cancer Secretome. Promotes a Tumor-Supportive Immune. Microenvironment via CCR2
Molecular Cell, Volume 65 Supplemental Information The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2 Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt,
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature11809 Supplementary Figure 1. Antibiotic treatment reduces intestinal bacterial load and allows access of non-pathogenic bacteria to the MLN, inducing intestinal
More informationIn vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang *
In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells Ningfei An, Yubin Kang * Division of Hematology-Oncology, Department of Medicine, Medical University of South Carolina, Charleston,
More informationSUPPLEMENTARY INFORMATION
DOI: 10.1038/ncb3240 Supplementary Figure 1 GBM cell lines display similar levels of p100 to p52 processing but respond differentially to TWEAK-induced TERT expression according to TERT promoter mutation
More informationHematopoietic stem cell transplantation without irradiation
nature methods Hematopoietic stem cell transplantation without irradiation Claudia Waskow, Vikas Madan, Susanne Bartels, Céline Costa, Rosel Blasig & Hans-Reimer Rodewald Supplementary figures and text:
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Legends for Supplementary Tables. Supplementary Table 1. An excel file containing primary screen data. Worksheet 1, Normalized quantification data from a duplicated screen: valid
More informationNature Immunology: doi: /ni Supplementary Figure 1. Time course of OT-II T reg cell development in thymic slices.
Supplementary Figure 1 Time course of OT-II T reg cell development in thymic slices. Time course of T reg cell development following addition of OT-II TCR transgenic Rag2 -/- mice (OT-II) thymocytes to
More informationNew treatments in the pipeline for MPN. Claire Harrison Guy s and St Thomas Hospital NHS Foundation Trust, London, UK
New treatments in the pipeline for MPN Claire Harrison Guy s and St Thomas Hospital NHS Foundation Trust, London, UK Beyond JAK2 V617F Mutation: Molecular Complexity of MPNs Mutations affecting the JAK-STAT
More informationRer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease
Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein mutant that causes type 1A Charcot-Marie-Tooth disease Taichi Hara, Yukiko Hashimoto, Tomoko Akuzawa, Rika Hirai,
More informationNature Medicine: doi: /nm.4464
Supplementary Fig. 1. Amino acid transporters and substrates used for selectivity screening. (A) Common transporters and amino acid substrates shown. Amino acids designated by one-letter codes. Transporters
More informationThe trithorax protein partner menin acts in tandem with EZH2 to suppress C/EBPα and differentiation in MLL-AF9 leukemia
SUPPLEMENTARY APPENDIX The trithorax protein partner menin acts in tandem with EZH2 to suppress C/EBPα and differentiation in MLL-AF9 leukemia Austin T. Thiel, Zijie Feng, Dhruv K. Pant, Lewis A. Chodosh,
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature12138 Supplementary Figure 1. Knockdown of KRAS leads to a reduction in macropinocytosis. (a) KRAS knockdown in MIA PaCa-2 cells expressing KRASspecific shrnas
More informationSupplementary Figure 1
Supplementary Figure 1 Supplementary Figure 1: Vector maps of TRMPV and TRMPVIR variants. Many derivatives of TRMPV have been generated and tested. Unless otherwise noted, experiments in this paper use
More informationMa, et al. Supplemental Data
Ma, et al Supplemental Data Title: Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension and its inhibition attenuates pathologic features of disease Authors: Wanli
More informationFlowcytometry-based purity analysis of peritoneal macrophage culture.
Liao et al., KLF4 regulates macrophage polarization Revision of Manuscript 45444-RG- Supplementary Figure Legends Figure S Flowcytometry-based purity analysis of peritoneal macrophage culture. Thioglycollate
More informationSupplementary information to accompany: A novel role for the DNA repair gene Rad51 in Netrin-1 signalling
Supplementary information to accompany: A novel role for the DNA repair gene Rad51 in Netrin-1 signalling Glendining KA 1, Markie D 2, Gardner RJM 4, Franz EA 3, Robertson SP 4, Jasoni CL 1 Supplementary
More informationSupplementary Figure 1: Overexpression of EBV-encoded proteins Western blot analysis of the expression levels of EBV-encoded latency III proteins in
Supplementary Figure 1: Overexpression of EBV-encoded proteins Western blot analysis of the expression levels of EBV-encoded latency III proteins in BL2 cells. The Ponceau S staining of the membranes or
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature12474 Supplementary Figure 1 Analysis of mtdna mutation loads in different types of mtdna mutator mice. a, PCR, cloning, and sequencing analysis of mtdna mutations
More informationSUPPLEMENTARY INFORMATION
VOLUME: 1 ARTICLE NUMBER: 0011 In the format provided by the authors and unedited. In situ Activation of Platelets with Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy Chao Wang 1, 2, Wujin
More informationCancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumor blood vessels Supplementary Information
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumor blood vessels Supplementary Information 1. Supplementary Figure S1-S10: Pages 2-11 2. Supplementary References:
More informationMyofibroblasts in kidney fibrosis. LeBleu et al.
Origin and Function of Myofibroblasts in Kidney Fibrosis Valerie S. LeBleu, Gangadhar Taduri, Joyce O Connell, Yingqi Teng, Vesselina G. Cooke, Craig Woda, Hikaru Sugimoto and Raghu Kalluri Supplementary
More informationTumour 2. Tumour 9. Tumour 25 Tumour 26. Tumour 27. t(6;16) doi: /nature06159 SUPPLEMENTARY INFORMATION Supplementary Figure 1
doi: 1.18/nature6159 SUPPLEMENTARY INFORMATION Supplementary Figure 1 Tumour Tumour 9 t(6;16) Tumour 5 Tumour 6 Tumour 7 www.nature.com/nature 1 doi: 1.18/nature6159 SUPPLEMENTARY INFORMATION Supplementary
More informationSupplemental Figure 1. HepG2 cells were transfected with GLI luciferase reporter construct
Supplemental Figure 1. HepG2 cells were transfected with GLI luciferase reporter construct (pgl38xgli), EWS-FLI1 luciferase reporter construct (NROB1-Luc) with or without GLI1, EWS- FLI1 and cdnas respectively.
More informationYalin Emre, Magali Irla, Isabelle Dunand- Sauthier, Romain Ballet, Mehdi Meguenani, Stephane Jemelin, Christian Vesin, Walter Reith and Beat A.
Supplementary information Thymic epithelial cell expansion through matricellular protein CYR61 boosts progenitor homing and T- cell output Yalin Emre, Magali Irla, Isabelle Dunand- Sauthier, Romain Ballet,
More information